30 Mar 2017 | 4:48 AM
 

Bafna Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532989 | NSE Symbol: BAFNAPHARM
29.50
-0.30
(-1.00 %)
29 Mar 2017 | 03:41 PM
Change company
  • Open (Rs)
    30.30
  • Prev. close (Rs.)
    29.80
  • High (Rs.)
    30.35
  • Low (Rs.)
    29.50
  • 52W H (Rs.)
    35.80
  • 52W L (Rs.)
    26.25
  • Volume (Rs.)
    9557
  • MCap (Rs in Cr.)
    55.04
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-7.52
Operating Margin (%)
0.60
Gross Profit Margin (%)
-5.08
Net Profit Margin (%)
-16.44
Total Debt/Equity
1.39
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

10 Jun 2015 - 11:12:00-Drug maker Bafna Pharmaceuticals Ltd on Wednesday said it has received the renewal certificate from ...
28 Oct 2014 - 11:15:00-Bafna Pharmaceuticals today said that it has appointed RS Gowdhaman as Company Secretary & Complianc...
26 Nov 2013 - 09:51:00-Shares of drug maker Bafna Pharmaceuticals rallied over 19 per cent in early trade on Bombay Stock E...
21 May 2013 - 15:06:00-Bafna Pharmaceuticals Ltd. has posted net loss of Rs 0...

Announcements

18-Mar-2017
Bafna Pharmaceutical - Outcome of Committee Meeting
14-Mar-2017
Bafna Pharmaceutical - Outcome of Board Meeting
10-Mar-2017
Bafna Pharmaceutical - Board Meeting on Mar 14 2017
11-Feb-2017
Bafna Pharmaceuticals Ltd. - Shareholders meeting
04-Feb-2017
Bafna Pharmaceutical - Board Meeting Intimation for Results

Religare Research

29 Mar 2017 | 12:21 PM
Agri Fundamental and Technical report
29 Mar 2017 | 09:47 AM
The Indian rupee rose to a 17-month high against the dollar, as U.S. President Donald Trump's failur...
29 Mar 2017 | 09:22 AM
• Gold steadied as investors weighed Trump agenda prospects • US natural gas regained strength amid...
29 Mar 2017 | 07:00 AM
We expect volatility to increase in the next two sessions due to scheduled derivatives expiry.Trader...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors33.42%
Mutual Funds/UTI0.00%
FI/Banks0.07%
Insurance0.07%
FII0.00%
Government0.00%
Others16.01%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,445.50(-2.86)
3578
 Kovai Medical Center and Hospital Ltd.
1,310.00(1.58)
11816
 Merck Ltd.
1,032.00(-2.41)
3302
 AstraZeneca Pharma India Ltd.
930.55(-0.39)
3274

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Bafna Pharmaceuticals Ltd.-1.001.200.05
NIFTY(S&P CNX)264.201,040.20552.55
BSE SENSEX788.113,165.281,703.90
BSE 500370.821,616.25944.65

Corporate Details

Key Personal
B Kamlesh Kumar
Ind. Non-Executive Director
Bafna Mahaveer Chand
Chairman & Managing Director
K Sabitha
Non Ind.& Exe.Director
Key Address
Registered Office
Bafna Towers New?No.?68 ?Old?No. 299 ?? ? Thambu Chetty Street,Chennai (Madras),Tamil Nadu

Tel:044-25267517 42677555 25270992, Fax:044-25231264 42677599

info@bafnapharma.com
http://www.bafnapharma.com
Registrar Office
Cameo Corporate Services Ltd.
Add. :Subramanian Building No.1 Vth Floor Club House Road

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Bafna Pharmaceuticals Ltd. that will help you decide whether to buy, sell or hold Bafna Pharmaceuticals Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Bafna Pharmaceuticals Ltd.